Clinical trial
A Trial in Participants With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate the Impact of Vapendavir on the Development of Lower Respiratory Tract Symptoms Following Rhinovirus Challenge
NCT06149494 is registered in ClinicalTrials.gov with Altesa Biosciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial in Participants With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate the Impact of Vapendavir on the Development of Lower Respiratory Tract Symptoms Following Rhinovirus Challenge
- Lead sponsor
- Altesa Biosciences, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 20, 2023
- Completion date
- March 30, 2025
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lower respiratory diseases, chronic respiratory disease, copd, copd exacerbation acute, copd with acute lower respiratory infection, emphysema or copd, enterovirus, enterovirus infections, infection viral, infections, infections, respiratory, lower respiratory disease, lower respiratory disorder, lower respiratory tract and lung infections, lung disease chronic, lung diseases, obstructive pulmonary disease, pulmonary disease, pulmonary disease, chronic obstructive, respiratory complication, respiratory disease, respiratory disease chronic, respiratory tract diseases, respiratory tract infections, respiratory viral infection, rhinovirus, rhinovirus infection, upper resp tract infection, upper respiratory disease, upper respiratory disease, acute, upper respiratory disorder, upper respiratory infection viral, upper respiratory tract infections, viral infection, virus diseases, virus infection, rna